Search tips
Search criteria 


Logo of jrsocmedLink to Publisher's site
J R Soc Med. 2002; 95(Suppl 42): 23–32.
PMCID: PMC1308941

The roles of insulin and fatty acids in the regulation of hepatic very-low-density lipoprotein assembly.

Full Text

The Full Text of this article is available as a PDF (597K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Woodside WF, Heimberg M. Effects of anti-insulin serum, insulin, and glucose on output of triglycerides and on ketogenesis by the perfused rat liver. J Biol Chem. 1976 Jan 10;251(1):13–23. [PubMed]
  • Sparks JD, Sparks CE, Miller LL. Insulin effects on apolipoprotein B production by normal, diabetic and treated-diabetic rat liver and cultured rat hepatocytes. Biochem J. 1989 Jul 1;261(1):83–88. [PubMed]
  • Topping DL, Mayes PA. The immediate effects of insulin and fructose on the metabolism of the perfused liver. Changes in lipoprotein secretion, fatty acid oxidation and esterification, lipogenesis and carbohydrate metabolism. Biochem J. 1972 Jan;126(2):295–311. [PubMed]
  • Zammit VA, Lankester DJ, Brown AM, Park BS. Insulin stimulates triacylglycerol secretion by perfused livers from fed rats but inhibits it in livers from fasted or insulin-deficient rats implications for the relationship between hyperinsulinaemia and hypertriglyceridaemia. Eur J Biochem. 1999 Aug;263(3):859–864. [PubMed]
  • Durrington PN, Newton RS, Weinstein DB, Steinberg D. Effects of insulin and glucose on very low density lipoprotein triglyceride secretion by cultured rat hepatocytes. J Clin Invest. 1982 Jul;70(1):63–73. [PMC free article] [PubMed]
  • Bartlett SM, Gibbons GF. Short- and longer-term regulation of very-low-density lipoprotein secretion by insulin, dexamethasone and lipogenic substrates in cultured hepatocytes. A biphasic effect of insulin. Biochem J. 1988 Jan 1;249(1):37–43. [PubMed]
  • Patsch W, Gotto AM, Jr, Patsch JR. Effects of insulin on lipoprotein secretion in rat hepatocyte cultures. The role of the insulin receptor. J Biol Chem. 1986 Jul 25;261(21):9603–9606. [PubMed]
  • Sparks JD, Sparks CE. Insulin modulation of hepatic synthesis and secretion of apolipoprotein B by rat hepatocytes. J Biol Chem. 1990 May 25;265(15):8854–8862. [PubMed]
  • Salhanick AI, Schwartz SI, Amatruda JM. Insulin inhibits apolipoprotein B secretion in isolated human hepatocytes. Metabolism. 1991 Mar;40(3):275–279. [PubMed]
  • Salter AM, Wiggins D, Sessions VA, Gibbons GF. The intracellular triacylglycerol/fatty acid cycle: a comparison of its activity in hepatocytes which secrete exclusively apolipoprotein (apo) B100 very-low-density lipoprotein (VLDL) and in those which secrete predominantly apoB48 VLDL. Biochem J. 1998 Jun 15;332(Pt 3):667–672. [PubMed]
  • Byrne CD, Wang TW, Hales CN. Control of Hep G2-cell triacylglycerol and apolipoprotein B synthesis and secretion by polyunsaturated non-esterified fatty acids and insulin. Biochem J. 1992 Nov 15;288(Pt 1):101–107. [PubMed]
  • Bülow J, Simonsen L, Wiggins D, Humphreys SM, Frayn KN, Powell D, Gibbons GF. Co-ordination of hepatic and adipose tissue lipid metabolism after oral glucose. J Lipid Res. 1999 Nov;40(11):2034–2043. [PubMed]
  • Bourgeois CS, Wiggins D, Gibbons GF. Chronic exogenous hyperinsulinaemia does not modify the acute inhibitory effect of insulin on the secretion of very-low-density lipoprotein triacylglycerol and apolipoprotein B in primary cultures of rat hepatocytes. Biochem J. 1996 Feb 15;314(Pt 1):103–108. [PubMed]
  • Brown AM, Gibbons GF. Insulin inhibits the maturation phase of VLDL assembly via a phosphoinositide 3-kinase-mediated event. Arterioscler Thromb Vasc Biol. 2001 Oct;21(10):1656–1661. [PubMed]
  • Duerden JM, Bartlett SM, Gibbons GF. Long-term maintenance of high rates of very-low-density-lipoprotein secretion in hepatocyte cultures. A model for studying the direct effects of insulin and insulin deficiency in vitro. Biochem J. 1989 Nov 1;263(3):937–943. [PubMed]
  • Duerden JM, Gibbons GF. Storage, mobilization and secretion of cytosolic triacylglycerol in hepatocyte cultures. The role of insulin. Biochem J. 1990 Dec 15;272(3):583–587. [PubMed]
  • Gibbons GF, Islam K, Pease RJ. Mobilisation of triacylglycerol stores. Biochim Biophys Acta. 2000 Jan 3;1483(1):37–57. [PubMed]
  • Pullinger CR, North JD, Teng BB, Rifici VA, Ronhild de Brito AE, Scott J. The apolipoprotein B gene is constitutively expressed in HepG2 cells: regulation of secretion by oleic acid, albumin, and insulin, and measurement of the mRNA half-life. J Lipid Res. 1989 Jul;30(7):1065–1077. [PubMed]
  • Yao Z, Tran K, McLeod RS. Intracellular degradation of newly synthesized apolipoprotein B. J Lipid Res. 1997 Oct;38(10):1937–1953. [PubMed]
  • Reaven GM, Mondon CE. Effect of in vivo plasma insulin levels on the relationship between perfusate free fatty acid concentration and triglyceride secretion by perfused rat livers. Horm Metab Res. 1984 May;16(5):230–232. [PubMed]
  • Gibbons GF. Hyperlipidaemia of diabetes. Clin Sci (Lond) 1986 Nov;71(5):477–486. [PubMed]
  • Bourgeois CS, Wiggins D, Hems R, Gibbons GF. VLDL output by hepatocytes from obese Zucker rats is resistant to the inhibitory effect of insulin. Am J Physiol. 1995 Aug;269(2 Pt 1):E208–E215. [PubMed]
  • Wiggins D, Hems R, Gibbons GF. Decreased sensitivity to the inhibitory effect of insulin on the secretion of very-low-density lipoprotein in cultured hepatocytes from fructose-fed rats. Metabolism. 1995 Jul;44(7):841–847. [PubMed]
  • Bourgeois CS, Gibbons GF. Decreased sensitivity of very-low-density lipoprotein secretion to the inhibitory effect of insulin in cultured hepatocytes from lactating rats. Biochem J. 1996 Jun 15;316(Pt 3):737–741. [PubMed]
  • Reaven GM. The fourth musketeer--from Alexandre Dumas to Claude Bernard. Diabetologia. 1995 Jan;38(1):3–13. [PubMed]
  • McGarry JD. Malonyl-CoA and carnitine palmitoyltransferase I: an expanding partnership. Biochem Soc Trans. 1995 Aug;23(3):481–485. [PubMed]
  • Lewis GF, Uffelman KD, Szeto LW, Steiner G. Effects of acute hyperinsulinemia on VLDL triglyceride and VLDL apoB production in normal weight and obese individuals. Diabetes. 1993 Jun;42(6):833–842. [PubMed]
  • Malmström R, Packard CJ, Caslake M, Bedford D, Stewart P, Yki-Järvinen H, Shepherd J, Taskinen MR. Defective regulation of triglyceride metabolism by insulin in the liver in NIDDM. Diabetologia. 1997 Apr;40(4):454–462. [PubMed]
  • Lewis GF, Uffelman KD, Szeto LW, Weller B, Steiner G. Interaction between free fatty acids and insulin in the acute control of very low density lipoprotein production in humans. J Clin Invest. 1995 Jan;95(1):158–166. [PMC free article] [PubMed]
  • Vogelberg KH, Gries FA, Moschinski D. Hepatic production of VLDL-triglycerides. Dependence of portal substrate and insulin concentration. Horm Metab Res. 1980 Dec;12(12):688–694. [PubMed]
  • Lewis GF, Zinman B, Uffelman KD, Szeto L, Weller B, Steiner G. VLDL production is decreased to a similar extent by acute portal vs. peripheral venous insulin. Am J Physiol. 1994 Oct;267(4 Pt 1):E566–E572. [PubMed]
  • Sidossis LS, Mittendorfer B, Walser E, Chinkes D, Wolfe RR. Hyperglycemia-induced inhibition of splanchnic fatty acid oxidation increases hepatic triacylglycerol secretion. Am J Physiol. 1998 Nov;275(5 Pt 1):E798–E805. [PubMed]
  • Brown AM, Wiggins D, Gibbons GF. Glucose phosphorylation is essential for the turnover of neutral lipid and the second stage assembly of triacylglycerol-rich ApoB-containing lipoproteins in primary hepatocyte cultures. Arterioscler Thromb Vasc Biol. 1999 Feb;19(2):321–329. [PubMed]
  • Olofsson SO, Asp L, Borén J. The assembly and secretion of apolipoprotein B-containing lipoproteins. Curr Opin Lipidol. 1999 Aug;10(4):341–346. [PubMed]
  • Packard CJ. Understanding coronary heart disease as a consequence of defective regulation of apolipoprotein B metabolism. Curr Opin Lipidol. 1999 Jun;10(3):237–244. [PubMed]
  • Owen MR, Corstorphine CC, Zammit VA. Overt and latent activities of diacylglycerol acytransferase in rat liver microsomes: possible roles in very-low-density lipoprotein triacylglycerol secretion. Biochem J. 1997 Apr 1;323(Pt 1):17–21. [PubMed]
  • Trickett JI, Patel DD, Knight BL, Saggerson ED, Gibbons GF, Pease RJ. Characterization of the rodent genes for arylacetamide deacetylase, a putative microsomal lipase, and evidence for transcriptional regulation. J Biol Chem. 2001 Oct 26;276(43):39522–39532. [PubMed]
  • Phung TL, Roncone A, Jensen KL, Sparks CE, Sparks JD. Phosphoinositide 3-kinase activity is necessary for insulin-dependent inhibition of apolipoprotein B secretion by rat hepatocytes and localizes to the endoplasmic reticulum. J Biol Chem. 1997 Dec 5;272(49):30693–30702. [PubMed]
  • Gibbons GF, Wiggins D. Intracellular triacylglycerol lipase: its role in the assembly of hepatic very-low-density lipoprotein (VLDL). Adv Enzyme Regul. 1995;35:179–198. [PubMed]
  • Wiggins D, Gibbons GF. Origin of hepatic very-low-density lipoprotein triacylglycerol: the contribution of cellular phospholipid. Biochem J. 1996 Dec 1;320(Pt 2):673–679. [PubMed]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press